| EFSA | European Food Safety Authority |
| BMI | body mass index |
| HbA1c | glycated hemoglobin |
| FBG | fasting blood glucose |
| TC | total cholesterol |
| TG | triglycerides |
| H2O2 | hydrogen peroxide |
| SI | serum insulin |
| FSI | fasting serum insulin |
| ROS | reactive oxygen species |
| NF-κβ | nuclear factor-κβ |
| NADH | nicotinamide adenine dinucleotide + hydrogen |
| HOMA-IR | homeostasis model assessment insulin resistance |
| GLUT-4 | glucose transporter type 4 |
| GLUT-1 | glucose transporter type 1 |
| PPG60min | postprandial glucose level (60 min) |
| PPG30min | postprandial glucose level (30 min) |
| PPG120min | postprandial glucose level (120 min) |
| OGTT | oral glucose tolerance test |
| NOAEL | not observed adverse effect level |
| DPPH | 2,2-diphenyl-1-picrylhydrazyl |
| ABTS | 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) |
| FRAP | ferric reducing antioxidant power |
| LDL | low-density lipoprotein |
| UCP-1 | uncoupling protein 1 |
| PPAR-α | peroxisome proliferator-activated receptor alpha |
| CRP | C-reactive protein |
| FDA | Food and Drug Administration |